| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Idexx Laboratories Inc /de (IDXX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 49 sells. IDXX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 82.4K | $44.99M | - | |
| VP | 13.7K | $7.46M | - | |
| VP | 10.4K | $5.69M | - | |
| VP | 6.3K | $3.46M | - | |
| VP | 1.6K | $875.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 7, 2020 | Ayers Jonathan W63 | Director | Sell | 39,600 | $281.07 | $11,130,402.00 | -10.7% | |
| Feb 21, 2020 | Ayers Jonathan W63 | Director | Sale+OE | 23,400 | $284.92 | $6,667,109.23 | -0.3% | |
| Feb 19, 2020 | Ayers Jonathan W63 | Director | Sell | 39,143 | $293.62 | $11,493,155.19 | -0.3% | |
| Feb 18, 2020 | Ayers Jonathan W63 | Director | Sell | 40,000 | $286.84 | $11,473,578.47 | -1.2% | |
| Feb 18, 2020 | Vandebroek Sophie V. | Director | Sale+OE | 7,568 | $286.89 | $2,171,202.44 | -53.3% | |
| Feb 18, 2020 | Szostak M Anne | Director | Sale+OE | 8,790 | $286.29 | $2,516,469.42 | -55.6% | |
| Feb 5, 2020 | Mazelsky Jonathan Jay63 | President &CEO | Sale+OE | 8,000 | $277.84 | $2,222,692.11 | -2.9% | |
| Nov 29, 2019 | Twigge Giovani | Corporate Vice President | Sale+OE | 14,750 | $250.51 | $3,695,006.93 | -30.3% | |
| Nov 12, 2019 | Ayers Jonathan W63 | Director, Senior Advisor | Sell | 36,000 | $254.05 | $9,145,940.41 | -1.9% | |
| Nov 7, 2019 | Ayers Jonathan W63 | Director, Senior Advisor | Sell | 37,790 | $263.09 | $9,942,081.51 | -1.3% |